Viewing Study NCT01114620


Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2025-12-26 @ 3:11 AM
Study NCT ID: NCT01114620
Status: COMPLETED
Last Update Posted: 2019-11-05
First Post: 2010-04-29
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-05-17
Start Date Type: ACTUAL
Primary Completion Date: 2010-11-05
Primary Completion Date Type: ACTUAL
Completion Date: 2010-12-09
Completion Date Type: ACTUAL
First Submit Date: 2010-04-29
First Submit QC Date: None
Study First Post Date: 2010-05-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-05-08
Results First Submit QC Date: None
Results First Post Date: 2017-12-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2012-10-15
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2019-10-28
Last Update Post Date: 2019-11-05
Last Update Post Date Type: ACTUAL